ZofranLegal.com reports on an order given by the Honorable F. Dennis Saylor IV, who is currently overseeing the lawsuits involved in Zofran MDL number 2657. This new order will help to simplify the typical lawsuit filing process for those looking to file and join the MDL. Judge Saylor IV has announced that potential plaintiffs who are interested in filing Zofran lawsuits of their own will now be able to do so directly into the MDL, skipping the typical process of filing in local federal courts and then transferring their lawsuit.
The MDL consolidation was ordered by the U.S. Judicial Panel on Multidistrict Litigation, and was possible because all of the filed lawsuits involved similar plaintiff allegations against the same defendant. The consolidation is intended to help fast-track the legal process by eliminating duplicative discovery and different rulings from multiple judges. It also helps to conserve time and finances for everyone involved.
The MDL lawsuits are being housed in a single Court in Boston, Massachusetts and currently number over 230 cases. Plaintiffs involved allege that fetal exposure to anti-nausea drug Zofran caused their children to be born with a range of severe and sometimes fatal defects. The defects most commonly noted in Zofran lawsuits are transposition of the greater vessels, atrial septal defect and ventricular septal defect, kidney defects, clubfoot, respiratory distress, and cleft lip and palate. They have been filed against pharmaceutical giant GlaxoSmithKline.
This new court order is the 6th to have been announced by Judge Saylor, and plaintiffs involved anxiously await other order while Zofran lawsuit numbers continue to grow.
The attorneys of Monheit Law understand how concerning this information can be for pregnant women who have taken Zofran to treat morning sickness. The drug was never FDA-approved for this use, and Monheit Law attorneys are currently looking to assist other mothers who used Zofran while pregnant and later gave birth to children with defects. They want to ensure that these women will be given the important opportunity of investigating their legal rights in the matter. Affected parties could be entitled to substantial compensation gained through legal action. To help facilitate those wishing to explore their rights, the attorneys of Monheit Law are also offering free legal consultations for qualified patients at this time.
To request additional information on Zofran birth defect lawsuits, or to ask questions, please contact Michael Monheit, Esq. by calling (877) 620-8411.
Sponsored by an alliance of attorneys, ZofranLegal.com is a resource for parents, families and birth defect survivors interested in learning more about litigation surrounding the nausea drug Zofran and its link to increased risks of major birth defects.
1368 Barrowdale Road, Rydal, PA 19046
April 30, 2016 – Lawsuit Alleges Invokana Side Effects Can Include Diabetic Ketoacidosis, a Life-Threatening Condition Related to Too Much Acid in the Body
April 29, 2016 – Zofran Lawsuit Update: Plaintiffs Question Why GSK Hasn’t Faced Stiffer Penalties
April 27, 2016 – Arkansas Mother Files Zofran Lawsuit Claiming Multiple Defects Caused By Drug
April 25, 2016 – Zofran Lawsuit Plaintiffs Applaud FDA’s Decision Regarding Folic Acid
April 22, 2016 – MyFoxBoston News Release Discusses Concerning Zofran Birth Defect Lawsuits And Drug Safety
April 22, 2016 – Zofran Lawsuit Plaintiffs Note Results Of Japanese Animal Studies Linking Birth Defects To Drug
April 22, 2016 – A Look Back At America’s First Zofran Lawsuit
April 21, 2016 – Significant Increase In Birth Defect Development Investigated By Washington State Amid Mounting Zofran Lawsuits
April 21, 2016 – Zofran Lawsuit Plaintiffs Make Note Of Canadian Label Differences On Drug Which Warn Of Use During Pregnancy
April 20, 2016 – Zofran Lawsuit Plaintiff Claims Infant’s Cleft Palate, Clubfoot, And Respiratory Distress Caused By Drug Exposure
